Effects of pramipexole on depression in Parkinson's disease
10.3760/cma.j.issn.1008-6706.2015.17.020
- VernacularTitle:普拉克索治疗帕金森病合并抑郁疗效观察
- Author:
Lili GAO
;
Dehua SUN
;
Wei CHEN
- Publication Type:Journal Article
- Keywords:
Pramipexole;
Parkinson's disease;
Depression;
Clinical efficacy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(17):2619-2621
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate and analysis the clinical effect of pramipexole in Parkinson's disease with depression.Methods The patients with Parkinson disease patients with depression were selected in a total of 100 as the research object,and were randomly divided into two groups,the observation group and the control group with 50 cases in each group.The control group was taken conventional treatment,the observation group was given pramipexole based on the conventional treatment methods,the the effects of treatment were observed and compared. Results The MIHD score of the observation group after treated for 12 month (8.26 ±1.96)was lower than the score before treatment (24.91 ±4.6),and the score of the control group after treated for 12 month (11.15 ±2.10)was also lower than the score before treatment (24.48 ±5.34),the difference were all statistically significant(P<0.05). After treated for 12 month,the score in the observation group was lower than that in the control group,and the total effective rate in the two group were 94% and 80% respectively(P<0.05 ).The UPDRS score of the observation group was lower than in the control group,but the difference was not significant(χ2 =14.756,P<0.05).Conclusion Give pramipexole has notable curative effect on the depression disease in patients with Parkinson disease on the basis of conventional therapy method,and has the value of popularization.
